Learn more

FEDERAL NOE G BJUDZHETNOE UCHREZHDENIE NAUKI INST KHIM BIOLOG I FUNDAMENTAL NOJ MEDITSINY SIB OTDEL

Overview
  • Total Patents
    29
  • GoodIP Patent Rank
    151,293
About

FEDERAL NOE G BJUDZHETNOE UCHREZHDENIE NAUKI INST KHIM BIOLOG I FUNDAMENTAL NOJ MEDITSINY SIB OTDEL has a total of 29 patent applications. Its first patent ever was published in 2012. It filed its patents most often in Russian Federation. Its main competitors in its focus markets environmental technology are SOLOV EV VLADIMIR VLADIMIROVIC, KI NII EPIDEMIOLOGII INFEKTSIO and BELJAKOV NIKOLAJ VIKTOROVICH.

Patent filings in countries

World map showing FEDERAL NOE G BJUDZHETNOE UCHREZHDENIE NAUKI INST KHIM BIOLOG I FUNDAMENTAL NOJ MEDITSINY SIB OTDELs patent filings in countries
# Country Total Patents
#1 Russian Federation 29

Patent filings per year

Chart showing FEDERAL NOE G BJUDZHETNOE UCHREZHDENIE NAUKI INST KHIM BIOLOG I FUNDAMENTAL NOJ MEDITSINY SIB OTDELs patent filings per year from 1900 to 2020

Focus industries

Focus technologies

Top inventors

# Name Total Patents
#1 Vlasov Valentin Viktorovich 7
#2 Tikunova Nina Viktorovna 6
#3 Sil Nikov Vladimir Nikolaevich 6
#4 Morozova Vera Vital Evna 4
#5 Filipenko Maksim Leonidovich 4
#6 Koroleva Ljudmila Sergeevna 3
#7 Zakharova Ol Ga Dmitrievna 3
#8 Bojarskikh Ul Jana Aleksandrovna 3
#9 Nevinskij Georgij Aleksandrovich 3
#10 Laktionov Pavel Petrovich 3

Latest patents

Publication Filing date Title
RU2565559C1 STRAIN OF BACTERIOPHAGE Citrobacter freundii CF17 ABLE TO LYSE PATHOGENIC STRAINS CITROBACTER FREUNDII
RU2565824C1 STRAIN OF BACTERIOPHAGE Staphylococcus aureus SA20 ENSURING DESTRUCTION OF BIOFILMS CREATED BY BACTERIA OF Staphylococcus FAMILY
RU2565545C1 RECOMBINANT PLASMID DNA pFLAG-sc14D5a-Rm7 ENSURING SYNTHESIS OF HYBRID PROTEIN sc14D5a-Rm7, BACTERIA STRAIN Escherichia coli - PRODUCER OF HYBRID PROTEIN sc14D5a-Rm7, AND HYBRID PROTEIN sc14D5a-Rm7, COMBINING PROTEIN E OF TICK-BORNE ENCEPHALITIS MICE AND HAVING BIO-LUMINESCENCE ACTIVITY
RU2563171C1 Method of producing nanosized system for delivering azidothymidine triphosphate to mammalian cells
RU2571507C1 Diagnostic and monitoring technique for oncology diseases with use of blood exosomes
RU2558292C1 Method of isolating short rna from biological fluids
RU2556825C1 Method of extraction of exosomes from blood
RU2562857C1 RECOMBINANT PLAZMID DNA pCL2h-1I1G PROVIDING SYNTHESIS OF POLYPEPTIDE WITH PROPERTIES OF LIGHT CHAIN OF HUMAN ANTIBODY AGAINST INTERLEUKIN-18, RECOMBINANT PLAZMID DNA pCH2g-1I1G PROVIDING SYNTHESIS OF POLYPEPTIDE WITH PROPERTIES OF HEAVY CHAIN OF HUMAN ANTIBODY AGAINST INTERLEUKIN-18 AND RECOMBINANT HUMAN ANTIBODY fh1I1G WITH ABILITY TO BIND INTERLEUKIN-18
RU2563885C1 Method of identification of antibodies to bacterial anti-genes
RU2562117C1 Biochip and method of typing pathogens of group i which belongs to family of arena- and filoviruses
RU2549704C1 Rna-aptamer having ability to recognise autoantibodies specific to disseminated sclerosis
RU2550252C1 RECOMBINANT PLASMID DNA pCLm4/hygro-14D5 CODING POLYPEPTIDE WITH LIGHT CHAIN PROPERTIES OF CHIMERIC ANTIBODY TO TICK-BORNE ENCEPHALITIS VIRUS, AND RECOMBINANT PLASMID DNA pCHm2-14D5 CODING POLYPEPTIDE WITH HEAVY CHAIN PROPERTIES OF CHIMERIC ANTIBODY TO TICK-BORNE ENCEPHALITIS VIRUS, CHIMERIC ANTIBODY PROVIDING ACUTE PREVENTION OF TICK-BORNE ENCEPHALITIS IN MICE
RU2532328C1 Agent possessing antibacterial activity
RU2537000C1 Method of purification of vaccinia virus or its recombinant versions
RU2535676C1 Phosphorus-containing fluorinated 1,4-naphthoquinone derivatives, possessing cytotoxic activity with respect to human cancer cells in culture
RU2560591C2 Biochip and method typing genes of hemagglutinin and neuraminidase of influenza a virus
RU2552214C2 METHOD OF DETECTION OF Mycobacterium tuberculosis ISOLATES RESISTANT TO PYRAZINAMIDE
RU2527681C1 Method of obtaining nanosized system of nucleosidetriphosphate delivery into mammalian cells
RU2499789C1 Alkylating fluorinated 1,4-naphthoquinone derivatives having cytotoxic effect on human cancer cells in culture
RU2509808C1 METHOD FOR DETERMINING NON-SMALL CELLS LUNG CANCER SENSITIVITY TO PREPARATIONS REACTIVATING PROTEIN p53